Alembic Pharmaceuticals receives USFDA final approval for Pirfenidone tablets
The tablets have an estimated market size of US $ 548 million for twelve months ending December 2021 according to IQVIA
The tablets have an estimated market size of US $ 548 million for twelve months ending December 2021 according to IQVIA
The Portal BioRRAP will cater to all those seeking regulatory approval for biological research
If approved, ABBV-951 will offer patients the first continuous subcutaneous delivery of carbidopa/levodopa prodrugs
Positive opinion could expand the role of Cosentyx (secukinumab) in reducing flare risk in pediatric enthesitis-related arthritis (ERA) and psoriatic arthritis (PsA) patients in the EU
The new lab is a testament to the Pondicherry Institute of Medical Sciences (PIMS)’s long-held values and traditions of striving for excellence and embracing newer innovations in order to deliver the best standard of training for their students
First disclosure from PILOT study of Breyanzi in second-line large B-cell lymphoma underscores important role of cell therapy earlier in treatment paradigm
The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease
Dxcover announced that it will be presenting new data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 3-7
PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection
A primary investment of Rs 194.4 crore has been made
Subscribe To Our Newsletter & Stay Updated